Anesthesia and Cancer Recurrence: A New Sight

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Drug Development".

Deadline for manuscript submissions: 5 January 2025 | Viewed by 2872

Special Issue Editor


E-Mail Website
Guest Editor
Institut de Cancerologie Gustave Roussy, Villejuif, France
Interests: metabolism; cellular and molecular biology; cell signaling; cell death modality; epigenetic; cancer; immunity; oncoimmunology; anesthesiology; intensive care
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Surgery remains the best curative treatment for solid tumors. However, the direct manipulation of the tumor by the surgeon releases circulating tumor cells responsible for future metastases in distant organs. Moreover, acute pain and inflammation promote surgical stress inducing the release of inflammatory cytokines and neuroendocrine hormones, which negatively impact the immune system and contribute to an increase in relapses. Surprisingly, some retrospective studies observed that local anesthetics or intravenous hypnotics injected during oncological interventions improve the overall survival, while opioids and volatiles seem to favor second lesions and recurrences. These readouts seem to be confirmed in several preclinical investigations, and anesthetic protocols could impact oncological prognosis. Nevertheless, further evidence is required to confirm this hypothesis.

This Special Issue accepts all manuscripts that deal with analgesia, anesthesia, and surgery from basic to clinical research (original article, systematic review, etc.) and that address the recent findings highlighting the benefits, the difficulties, and the future of anesthesia management during the perioperative oncological surgery.

Potential topics include, but are not limited to:

  • Future perspectives for anesthesia management during oncological surgery;
  • Mechanisms of action of anesthetics on tumor cells;
  • Indications and limits of opioid-free anesthesia;
  • Advantages and side effects of opioids;
  • Local and regional anesthesia and relapses;
  • Advanced strategies to control surgical pain and avoid residual tumor cells;
  • Mini-invasive procedure and recurrences;
  • Surgical stress and recurrences.

Dr. Lucillia Bezu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • analgesia
  • anesthesia
  • cancer
  • immunity
  • local and regional anesthesia
  • opioid
  • recurrence
  • stress
  • surgery
  • volatile

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 2793 KiB  
Review
Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review
by Lucillia Bezu, Dilara Akçal Öksüz, Max Bell, Donal Buggy, Oscar Diaz-Cambronero, Mats Enlund, Patrice Forget, Anil Gupta, Markus W. Hollmann, Daniela Ionescu, Iva Kirac, Daqing Ma, Zhirajr Mokini, Tobias Piegeler, Giuseppe Pranzitelli, Laura Smith and The EuroPeriscope Group
Cancers 2024, 16(13), 2304; https://doi.org/10.3390/cancers16132304 - 22 Jun 2024
Viewed by 2366
Abstract
Surgical excision of the primary tumor represents the most frequent and curative procedure for solid malignancies. Compelling evidence suggests that, despite its beneficial effects, surgery may impair immunosurveillance by triggering an immunosuppressive inflammatory stress response and favor recurrence by stimulating minimal residual disease. [...] Read more.
Surgical excision of the primary tumor represents the most frequent and curative procedure for solid malignancies. Compelling evidence suggests that, despite its beneficial effects, surgery may impair immunosurveillance by triggering an immunosuppressive inflammatory stress response and favor recurrence by stimulating minimal residual disease. In addition, many factors interfere with the immune effectors before and after cancer procedures, such as malnutrition, anemia, or subsequent transfusion. Thus, the perioperative period plays a key role in determining oncological outcomes and represents a short phase to circumvent anesthetic and surgical deleterious factors by supporting the immune system through the use of synergistic pharmacological and non-pharmacological approaches. In line with this, accumulating studies indicate that anesthetic agents could drive both protumor or antitumor signaling pathways during or after cancer surgery. While preclinical investigations focusing on anesthetics’ impact on the behavior of cancer cells are quite convincing, limited clinical trials studying the consequences on survival and recurrences remain inconclusive. Herein, we highlight the main factors occurring during the perioperative period of cancer surgery and their potential impact on immunomodulation and cancer progression. We also discuss patient management prior to and during surgery, taking into consideration the latest advances in the literature. Full article
(This article belongs to the Special Issue Anesthesia and Cancer Recurrence: A New Sight)
Show Figures

Figure 1

Back to TopTop